The team intends to conduct additional studies to advance the adjuvant to Phase 1 safety trials, while also exploring its potential applications for a universal flu vaccine.
New Delhi: India’s first intranasal Covid vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller General of India for 18+ age group for restricted use in emergency situation. Announcing the achievements, Union Health Minister Mansukh Mandaviya termed it a ‘big boost to India’s fight against Covid-19. “Big Boost to India’s Fight […]
Hyderabad: Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to conduct Phase 3 trials of its Covid-19 intranasal vaccine, sources said on Monday. The Hyderabad-based vaccine maker has submitted the application and awaiting approval for Phase 3 trials of intranasal vaccine (BBV154). “Intranasal vaccines have the potential to prevent […]
